Department of Population Medicine, Harvard Pilgrim Health Care Institute, United States
Disclosure information not submitted.
1D-02 - Risk of Incident Supraventricular Tachycardia Following Exposure to Recombinant Zoster Vaccine in Adults ≥50 Years of Age in the United States
Sunday, August 24, 202510:45 AM - 11:00 AM ET
